Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 430,905 | reported | 02 Feb 2023 | tx 20+6,155,255−309,413 |
| TREVENA INC | 75,000 | reported | 28 Feb 2018 | tx 2+140,000 |
| GLYCOMIMETICS INC | 9,023 | reported | 23 Jun 2025 | tx 1+9,023 |
| Dianthus Therapeutics, Inc. /DE/ | 6,090 | reported | 21 May 2026 | tx 4+36,090 |
| Astria Therapeutics, Inc. | 0 | reported | 23 Jan 2026 | tx 15+511,986−526,642 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6,090 | 0.00 USD | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 263,321 | — | |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 8,333 | — | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 14,100 | — | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 14,100 | — | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 14,166 | — | deriv |
| 23 Jan 2026 | OTHER | Astria Therapeutics, Inc. | 26,550 | — | deriv |
| 23 Jun 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 9,023 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Astria Therapeutics, Inc. | 26,550 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 12,500 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Astria Therapeutics, Inc. | 14,100 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 11,000 | 0.00 USD | deriv |
| 11 Sept 2023 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6,500 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Astria Therapeutics, Inc. | 14,100 | 0.00 USD | deriv |
| 02 Feb 2023 | SALE | Viridian Therapeutics, Inc.\DE | 50,000 | 36.80 USD | |
| 09 Jun 2022 | GRANT_AWARD | Astria Therapeutics, Inc. | 8,333 | 0.00 USD | deriv |
| 01 Jun 2022 | SALE | Viridian Therapeutics, Inc.\DE | 30,000 | 12.20 USD | |
| 02 May 2022 | SALE | Viridian Therapeutics, Inc.\DE | 30,000 | 13.04 USD | |
| 01 Apr 2022 | SALE | Viridian Therapeutics, Inc.\DE | 26,400 | 18.92 USD | |
| 04 Apr 2022 | SALE | Viridian Therapeutics, Inc.\DE | 3,600 | 18.93 USD | |
| 02 Mar 2022 | SALE | Viridian Therapeutics, Inc.\DE | 11,106 | 17.36 USD | |
| 01 Mar 2022 | SALE | Viridian Therapeutics, Inc.\DE | 18,894 | 17.82 USD | |
| 01 Feb 2022 | SALE | Viridian Therapeutics, Inc.\DE | 16,751 | 19.55 USD | |
| 02 Feb 2022 | SALE | Viridian Therapeutics, Inc.\DE | 12,340 | 18.47 USD | |
| 03 Feb 2022 | SALE | Viridian Therapeutics, Inc.\DE | 909 | 19.16 USD | anomaly |